SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Published Date: 13 Mar 2023

Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...

Read Full News

Latest News

Weight-Loss Pill Approval Highlights Important Role of PCPs

FDA approval of Eli Lilly’s weight-loss pill on April 1 shows the fast-changing landscape for weight loss, obesity medications.

Thyroid Aging Patterns Can Predict Mortality Risk

Thyroid function changes modestly with age but shows greater variability from age 65 years onward, and distinct patterns of thyroid function change are linked to an increased risk for mortality.

Curcumin Supplementation May Help Ease Depression

Curcumin, the primary active compound in the spice turmeric, was associated with significant reduction in depressive symptoms in new research that has been characterized as ‘clinically meaningful.’

EMA Panel Backs Weekly Hormone for Child Growth Disorders

European regulators recommend expanding once-weekly growth hormone therapy to include children born small for gestational age and those with Noonan syndrome, potentially reducing injection burden.

Europe Moves Closer to New Retinal Disease Biosimilar

A new anti-VEGF biosimilar has moved closer to European approval for several vision-threatening retinal diseases, including choroidal neovascularization.

Dexcom Warns Patients as Stolen Glucose Sensors Hit the Market

Medical device maker Dexcom said on Tuesday some of its glucose ⁠sensors slated for destruction were instead stolen and sold, prompting the company ⁠to warn users not to use...

Todays Updates

Adjuvant Radiation Boosts High-Risk Bladder Cancer Control

For patients with high-risk muscle-invasive bladder cancer, adjuvant radiotherapy improves disease control without increasing the risk of serious side effects.

Blood Test Flags Mantle Cell Lymphoma Relapse Before PET-CT

Results pinpoint who has the worst prognosis and might benefit from different therapies.

Todays Updates

Adjuvant Radiation Boosts High-Risk Bladder Cancer Control

For patients with high-risk muscle-invasive bladder cancer, adjuvant radiotherapy improves disease control without increasing the risk of serious side effects.

Blood Test Flags Mantle Cell Lymphoma Relapse Before PET-CT

Results pinpoint who has the worst prognosis and might benefit from different therapies.

Latest News

FDA approval of Eli Lilly’s weight-loss pill on April 1 shows the fast-changing landscape for weight loss, obesity medications.

Thyroid function changes modestly with age but shows greater variability from age 65 years onward, and distinct patterns of thyroid function change are linked to an increased risk for mortality.

Curcumin, the primary active compound in the spice turmeric, was associated with significant reduction in depressive symptoms in new research that has been characterized as ‘clinically meaningful.’

European regulators recommend expanding once-weekly growth hormone therapy to include children born small for gestational age and those with Noonan syndrome, potentially reducing injection burden.

A new anti-VEGF biosimilar has moved closer to European approval for several vision-threatening retinal diseases, including choroidal neovascularization.

Medical device maker Dexcom said on Tuesday some of its glucose ⁠sensors slated for destruction were instead stolen and sold, prompting the company ⁠to warn users not to use...

News All Time

Diabetic Peripheral Neuropathy Tied to Dementia Risk in T2D

Diabetic peripheral neuropathy above a certain vibration perception threshold is linked to a notably higher risk for dementia in patients with type 2 diabetes, according to a Danish cohort study.

Finding the Next Weight-Loss Drug in Python Blood

Pythons can go weeks without eating. Now researchers have isolated an appetite-suppressing metabolite in python blood that could spur a new weight-loss therapy.

Diabetes Meds Show Varied Associations With Liver Protection

Different antidiabetic drug classes show distinct associations with the risk for major adverse liver outcomes among patients with type 2 diabetes, according to a network meta-analysis.

Could Digital Obesity Care Help Improve the Economy?

A UK digital obesity programme was associated with > 40% fewer GP visits and markedly lower long-term sick leave within 9 months in a real-world analysis.

CGM Reduces Complications, Mortality in T1D

Continuous glucose monitoring was associated with substantial reductions in diabetes-related complications and mortality in adults with type 1 diabetes in a large national study.

A Practical Guide to Make Digital Tools Work With GLP-1s

The learning curve can be steep for patients trying apps, wearables, and telehealth platforms. Your expertise is needed.

Diabetes Linked to Increased Cancer Risk in Hispanic Adults

Researchers determine time-varying diabetes measures and cancer incidence over time from a US multisite, prospective cohort study involving 16,415 Hispanic and Latino adults aged 18-74 years.

GLP-1s Curb Hunger; Snacks Keep Blood Sugar Stable

If three meals a day is too much, patients can turn to healthy snacks.

Hypothyroidism Drug May Cause Psychiatric Morbidity

The addition of liothyronine to levothyroxine treatment is associated with a higher risk for psychiatric morbidity in patients with autoimmune hypothyroidism.

Maternal Overnutrition Linked to Obesity in Adult Offspring

Maternal overnutrition is associated with a higher likelihood of obesity in adult offspring, with effects persisting into adulthood and being more pronounced in women.

Private-Sector Healthcare Rise May Affect Canadians’ Trust

As the number of privately funded providers and clinics in Canada increases, it may set up a two-tier system where those who can afford to pay out of pocket may have faster access to care.

French Regulators Fine Novo, Lilly Over GLP-1 Campaigns

French regulators say obesity awareness campaigns may blur the line between public education and the promotion of prescription weight-loss drugs.

EASO Update Gives Clearer Roles for Tirzepatide, Semaglutide

EASO’s ‘living’ algorithm has been updated with the latest evidence, strengthening tirzepatide’s position for weight loss and semaglutide’s role in liver fibrosis improvement.

Acute Kidney Injury Sets Kids Up for Chronic Kidney Disease

A meta-analysis finds increased long-term odds of chronic kidney disease and death in children who survive acute kidney injury.

Is Persistent Hunger After Weight Loss Behind Weight Regain?

People who regain lost weight may be biologically driven to do so via hyperphagia, an insatiable hunger and an intense preoccupation with food.

Cotrimoxazole Tied to More AEs in Older Men With UTIs

The use of cotrimoxazole is linked to about twice the risk of developing adverse events compared with the use of fluoroquinolones among older men with UTIs.

Recommended News For You

AI tool automates liver tumor detection and monitoring

Liquid Biopsies Cut EBV Burkitt Lymphoma Time to Diagnosis

Patients With Melanoma Brain Mets May Fare Better With RT Before Immunotherapy

Increased anti-tumor response and reduced side effects from immune checkpoint inhibitors.

Data-driven risk stratification guides childhood brain tumor treatment, reducing side effects

Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions

The FDA Approves the New Frontline Aggressive ALL Regimen.

Recommended Articles For You

All You Need To Know About Melanoma Maligna: Causes, Symptoms & Treatment 

Breaking Down Amyloidosis: Understanding the Disease  

The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology 

The Capmist DM: A Revolutionary Way to Combat Dry Mouth 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study Finds Microplastics Near Tumors; Experts Doubt Results

2.

High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy

3.

Screening for prostate cancer: is it time to give up digital rectal examination?

4.

Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer

5.

Neural networks and label-free microscopy enable accurate detection of pancreatic tumors

1.

Different Types of Blood Dyscrasias 

2.

Understanding the Importance of Red Cell Distribution Width (RDW) in Blood Tests 

3.

A Novel Gemcitabine-Releasing Intravesical System for Intermediate-Risk Non-Muscle-Invasive Bladder Cancer

4.

Exploring the Potential of Bendamustine in Cancer Treatment

5.

Mastering Prostate Cancer Care: CME, Certification, Digital Tools, and Evidence-Based Strategies

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC

2.

Updates on Standard V/S High Risk Myeloma Treatment

3.

Oropharyngeal Cancer in Relation to HPV Status

4.

Navigating the Complexities of Ph Negative ALL - Part X

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot